[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 8 sources · 10 days · First seen · Last updated

Bayer financial and glyphosate litigation management

Overview

Bayer is navigating financial and legal pressures related to its glyphosate-based products in the United States. Initially, the company’s stock experienced volatility and sideways movement on the XETRA exchange as investors awaited legal developments regarding glyphosate.

To manage high debt levels and significant legal costs, Bayer issued 2 billion euros in hybrid bonds, bringing its total outstanding hybrid bonds to 6.55 billion euros. This financing strategy is intended to provide financial flexibility and fund legal settlements, including a previous preliminary settlement valued at approximately 7.25 billion dollars, while mitigating impacts on the company’s credit rating.

Entities

Bayer · Leverkusen · DAX · glyphosate · Apollo

Timeline

  1. 4 days ago

    [BUSINESS] 6 sources
    Bayer raises 2 billion euros through hybrid bond issuance

    Bayer has issued 2 billion euros in 30-year hybrid bonds to bolster financial flexibility amid high debt and ongoing US glyphosate-related litigation.

  2. 14 days ago

    [BUSINESS] 2 sources
    Bayer stock faces volatility ahead of US glyphosate legal developments

    Bayer stock remains in a sideways trading pattern as investors await critical legal developments regarding glyphosate in the United States.

Sources

4investors.de · cash.ch · comparic.pl · finanzen.at · finanzen.ch · finanznachrichten.de · it-boltwise.de · kapitalmarktexperten.de